Simple Blood Ratio Flags Heart Risk in Women, but Falls Short as a Standalone Predictor
A Chinese cohort study of 3,123 women links a higher GGT-to-HDL-cholesterol ratio to coronary heart disease and future cardiovascular events, ...
Tag: major adverse cardiovascular events
Fibrosis Marker HE4 Predicts Death and Heart Attacks a Decade Out in Coronary Patients
A new ten-year study of nearly 400 angiographically confirmed coronary artery disease patients shows that the profibrotic protein HE4 independently ...
Bariatric Surgery Outperforms GLP-1 Drugs in Landmark Heart Risk Analysis
A network meta-analysis of 43 studies and over 930,000 patients finds bariatric surgery reduces major cardiovascular events, heart failure and ...
Heart Scans That Count Blood Flow Predict Who Faces Serious Cardiac Events, Study of 1,007 Patients Shows
A study of 1,007 patients shows that quantitative myocardial blood flow and flow reserve measured by dynamic CZT-SPECT independently predict ...
Oral Semaglutide Shows Real-World Heart Protection in Diabetes Patients with Cardiovascular Disease
A large real-world study found that adults with type 2 diabetes and atherosclerotic cardiovascular disease who started oral semaglutide had ...
Cardiovascular Risks of Antipsychotics in Severe Illness
In a groundbreaking study published in Nature Communications in 2025, researchers have unveiled critical insights into the cardiovascular safety profiles ...
Uric Acid Levels and Cardiovascular Risks in Seniors
Recent research has shed light on a critical yet often overlooked biomarker in the realm of cardiovascular health—serum uric acid. ...
Comparing Liraglutide, Semaglutide, and Dulaglutide in Veterans with Type 2 Diabetes
A recent comparative effectiveness study published in JAMA Network Open has provided new insights into the cardiovascular and renal outcomes ...
Combination of Two Cholesterol-Lowering Medications Could Save Thousands of Lives
Recent groundbreaking research has changed the paradigm of treatment for patients with cardiovascular diseases and elevated levels of low-density lipoprotein ...
Groundbreaking Medication for Diabetes, Heart Failure, and Kidney Disease Significantly Lowers Risk of Heart Attacks and Strokes
Sotagliflozin, an innovative drug approved by the Food and Drug Administration, represents a significant advancement in the treatment of type ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!